LRRK2 and Parkinson disease: We examined nascent proteins from fibroblasts isolated from the sporadic PD cases and healthy volunteers in Southwest Finland, and from cells of patients carrying a gain of function LRRK2-G2019S mutation, obtained from the National Institute of Neurological Disorders (NINDS) and Telethon Network of Genetic Biobanks (TNGB) repositories.